Subsidy Tracker Parent Company Summary

Parent Company Name: 
Alexion Pharmaceuticals
Ownership Structure: 
publicly traded (ticker symbol ALXN)
Headquartered in: 
Connecticut
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$79,705,5505
Federal (grants and allocated tax credits)$5,976,64410
TOTAL$85,682,19415
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$00
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$00
Time Period for State and Local Awards: 

Earliest year of data: 2012. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2013.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

ALEXION PHARMACEUTICALS; ENOBIA PHARMA; SYNAGEVA BIOPHARMA

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
Connecticut$77,000,0002
Massachusetts$2,705,5503

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Alexion Pharmaceuticals Connecticut state 2012 $51,000,000 tax credit/rebate
Alexion Pharmaceuticals, Inc Connecticut state 2013 $26,000,000 grant/loan hybrid program
ALEXION ANTIBODY TECHNOLOGIES United States federal 2005 $1,356,000 federal grant
Synageva BioPharma Massachusetts state 2014 $1,021,550 tax credit/rebate
Synageva BioPharma Corp Massachusetts state 2015 $900,000 tax credit/rebate
Synageva BioPharma Corp Massachusetts state 2013 $784,000 tax credit/rebate
ALEXION PHARMACEUTICALS, INC United States federal 2004 $737,620 federal grant
ALEXION PHARMACEUTICALS United States federal 2000 $732,800 federal grant
ALEXION PHARMACEUTICALS United States federal 2001 $647,896 federal grant
ALEXION PHARMACEUTICALS, INC United States federal 2005 $627,428 federal grant
ALEXION PHARMACEUTICALS United States federal 2000 $598,900 federal grant
ALEXION PHARMACEUTICALS, INC United States federal 2013 $400,000 federal grant
ALEXION PHARMACEUTICALS, INC United States federal 2013 $400,000 federal grant
ENOBIA PHARMA INC United States federal 2011 $400,000 federal grant
ALEXION ANTIBODY TECHNOLOGIES United States federal 2005 $76,000 federal grant
Alexion Pharmaceuticals Rhode Island state 2013 undisclosed tax credit/rebate
Download results as CSV or XML